Little Rick CBD Drink Mix Pack

The retailer catalogue identifies a mixed case of 330ml Little Rick drinks in Mint & Lime, Piña, Raspberry Coconut and Raspberry Lemonade. Each can is listed with 32mg CBD and the range is described as full spectrum, with CBD, CBG and CBC named in the structured product information. Those are retailer-supplied facts rather than results from independent testing by thCBDx, so the current can and any batch documentation remain the decisive sources.

The case is offered as 12 cans for £35.99 or 24 cans for £69.99 at the latest catalogue check. That works out at about £3.00 or £2.92 per can respectively. If every can contains the stated 32mg CBD, the cases represent 384mg or 768mg CBD in total. Showing both the per-can amount and whole-case arithmetic matters because a pack headline can otherwise make strength difficult to compare.

A stated 32mg CBD per can is materially above the Food Standards Agency's current precautionary advice that healthy adults should limit CBD from food to 10mg per day. That guidance is not a legal serving instruction and it is not a personalised dose recommendation, but it is essential context for a drink designed as a single 330ml container. People who are pregnant, breastfeeding, taking medication or otherwise in a potentially vulnerable group should follow the FSA's advice to avoid CBD unless advised by a medical professional.

The mixed case offers flavour choice, not strength choice: every listed can uses the same 32mg headline. A smaller per-container option would make the range easier to align with different preferences and current guidance. thCBDx does not award extra points for a larger CBD number and does not score reported relaxation, sleep, anxiety or other health outcomes.

Four flavours make the pack more informative than committing to a full case of one recipe. Mint & Lime points toward a mojito-like citrus and herb direction; Piña toward tropical pineapple; Raspberry Coconut toward fruit with a creamy association; and Raspberry Lemonade toward a sharper berry-citrus profile. These are useful selection cues, not objective tasting results.

Independent published commentary broadly recognises the same flavour identities. Gymfluencers described Raspberry Lemonade as a berry-led summer style and Mint & Lime in mojito terms, while an Infinity CBD range review particularly favoured Raspberry Lemonade and Mint & Lime. Those accounts help establish recurring sensory themes, but they are a small editorial sample and include subjective preferences. They do not justify claiming that every flavour is universally liked.

A sealed can is simpler to understand than measuring an oil and more socially familiar than a dropper bottle. It is also bulky: twelve 330ml cans contain almost four litres of drink before packaging, while a 24-pack is nearly eight litres. Individual cans are portable, but the case is not. Refrigeration preference, recycling and delivery weight should be considered alongside the attractive per-can calculation.

The 24-pack saves only around eight pence per can at the checked prices, so the larger upfront purchase is not automatically the better choice. The 12-pack provides the same flavour variety with less storage and commitment. Neither price includes a future promotion, and coupon-adjusted prices should be kept separate from the normal price history.

The strongest evidence here is the current structured specification: four named flavours, 330ml cans, 32mg CBD per can, two case sizes and clear prices. Independent flavour coverage adds useful context. Missing from the thCBDx record are a current batch-matched laboratory report, a large exact-product review sample and a lower-strength variant. Supplier-wide ratings cannot fill those gaps.

The final 7.5/10 recognises an unusually clear mixed-case proposition, reasonable per-can pricing and genuine flavour variety. It stops below the Highly Rated threshold because strength is fixed, the case format is bulky, exact-product feedback is still limited and the stated 32mg per can requires a prominent comparison with current FSA guidance. This is a well-presented comparison candidate—not a health recommendation.